These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 17913589)

  • 1. Aberrant sialylation of serum IgA1 was associated with prognosis of patients with IgA nephropathy.
    Ding JX; Xu LX; Lv JC; Zhao MH; Zhang H; Wang HY
    Clin Immunol; 2007 Dec; 125(3):268-74. PubMed ID: 17913589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum under-galactosylated IgA1 is increased in Japanese patients with IgA nephropathy.
    Shimozato S; Hiki Y; Odani H; Takahashi K; Yamamoto K; Sugiyama S
    Nephrol Dial Transplant; 2008 Jun; 23(6):1931-9. PubMed ID: 18178603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The glycans deficiencies of macromolecular IgA1 is a contributory factor of variable pathological phenotypes of IgA nephropathy.
    Xu LX; Yan Y; Zhang JJ; Zhang Y; Zhao MH
    Clin Exp Immunol; 2005 Dec; 142(3):569-75. PubMed ID: 16297170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant galactosylation of IgA1 is involved in the genetic susceptibility of Chinese patients with IgA nephropathy.
    Lin X; Ding J; Zhu L; Shi S; Jiang L; Zhao M; Zhang H
    Nephrol Dial Transplant; 2009 Nov; 24(11):3372-5. PubMed ID: 19531670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrantly glycosylated serum IgA1 are closely associated with pathologic phenotypes of IgA nephropathy.
    Xu LX; Zhao MH
    Kidney Int; 2005 Jul; 68(1):167-72. PubMed ID: 15954905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different glycosylation profile of serum IgA1 in IgA nephropathy according to the glomerular basement membrane thickness: normal versus thin.
    Linossier MT; Palle S; Berthoux F
    Am J Kidney Dis; 2003 Mar; 41(3):558-64. PubMed ID: 12612978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variants of the ST6GALNAC2 promoter influence transcriptional activity and contribute to genetic susceptibility to IgA nephropathy.
    Li GS; Zhu L; Zhang H; Lv JC; Ding JX; Zhao MH; Shen Y; Wang HY
    Hum Mutat; 2007 Oct; 28(10):950-7. PubMed ID: 17480010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. O-glycosylation of serum IgD in IgA nephropathy.
    Smith AC; de Wolff JF; Molyneux K; Feehally J; Barratt J
    J Am Soc Nephrol; 2006 Apr; 17(4):1192-9. PubMed ID: 16510764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral B lymphocyte beta1,3-galactosyltransferase and chaperone expression in immunoglobulin A nephropathy.
    Qin W; Zhou Q; Yang LC; Li Z; Su BH; Luo H; Fan JM
    J Intern Med; 2005 Nov; 258(5):467-77. PubMed ID: 16238683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct evidence for decreased sialylation and galactosylation of human serum IgA1 Fc O-glycosylated hinge peptides in IgA nephropathy by mass spectrometry.
    Odani H; Hiki Y; Takahashi M; Nishimoto A; Yasuda Y; Iwase H; Shinzato T; Maeda K
    Biochem Biophys Res Commun; 2000 Apr; 271(1):268-74. PubMed ID: 10777713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mass spectrometry analysis of IgA1 hinge region in patients with IgA nephropathy.
    Gastaldi D; Paradisi L; Baiocchi C; Medana C; Lo Duca G; Sena LM; Roccatello D
    J Nephrol; 2007; 20(6):689-95. PubMed ID: 18046671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgA-containing immune complexes in the urine of IgA nephropathy patients.
    Matousovic K; Novak J; Yanagihara T; Tomana M; Moldoveanu Z; Kulhavy R; Julian BA; Konecny K; Mestecky J
    Nephrol Dial Transplant; 2006 Sep; 21(9):2478-84. PubMed ID: 16757497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sialylation of IgG inhibits the formation of galactose-deficient IgA1-containing immune complexes and protects mesangial cells from injury in IgA nephropathy.
    Liu Y; Li H; Yu H; Wang F; Jia J; Yan T
    BMC Nephrol; 2022 Jan; 23(1):25. PubMed ID: 35016642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Removal systems of immunoglobulin A and immunoglobulin A containing complexes in IgA nephropathy and cirrhosis patients. The role of asialoglycoprotein receptors.
    Roccatello D; Picciotto G; Torchio M; Ropolo R; Ferro M; Franceschini R; Quattrocchio G; Cacace G; Coppo R; Sena LM
    Lab Invest; 1993 Dec; 69(6):714-23. PubMed ID: 8264233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. O-glycosylation of serum IgA1 antibodies against mucosal and systemic antigens in IgA nephropathy.
    Smith AC; Molyneux K; Feehally J; Barratt J
    J Am Soc Nephrol; 2006 Dec; 17(12):3520-8. PubMed ID: 17093066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural history of immunoglobulin A nephropathy and predictive factors of prognosis: a long-term follow up of 204 cases in China.
    Lv J; Zhang H; Zhou Y; Li G; Zou W; Wang H
    Nephrology (Carlton); 2008 Jun; 13(3):242-6. PubMed ID: 18221258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pathogenic role of IgA1 O-linked glycosylation in the pathogenesis of IgA nephropathy.
    Barratt J; Smith AC; Feehally J
    Nephrology (Carlton); 2007 Jun; 12(3):275-84. PubMed ID: 17498123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of interleukin-10 gene G-1082A polymorphism on recurrent IgA nephropathy.
    Bantis C; Heering PJ; Aker S; Schwandt C; Grabensee B; Ivens K
    J Nephrol; 2008; 21(6):941-6. PubMed ID: 19034880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An increased polymeric IgA level is not a prognostic marker for progressive IgA nephropathy.
    van der Boog PJ; van Kooten C; van Seggelen A; Mallat M; Klar-Mohamad N; de Fijter JW; Daha MR
    Nephrol Dial Transplant; 2004 Oct; 19(10):2487-93. PubMed ID: 15252166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the specific structures of IgA1 hinge glycopeptide in 30 IgA nephropathy patients by mass spectrometry.
    Odani H; Yamamoto K; Iwayama S; Iwase H; Takasaki A; Takahashi K; Fujita Y; Sugiyama S; Hiki Y
    J Nephrol; 2010; 23(1):70-6. PubMed ID: 20091489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.